News
China PharmaHub Signs Agreement with Chengdu Yongkon Pharmacy
August 18, 2010 8:35 am | by Bio-Medicine.Org | CommentsBOSTON, Aug. 18 /- China PharmaHub Corp. ("PharmaHub"), recently merged with World Wide Relics (OTC Bulletin Board: WRLC ), which will be shortly changing its name to China PharmaHub Corp, is proud to announce it has signed a cooperation agreement with Chengdu Yongkon Pharmacy Co. Ltd.,...
Omnicom Adds National Healthcare Giant to Client Roster
August 18, 2010 8:34 am | by Bio-Medicine.Org | CommentsFORT LAUDERDALE, Fla., Aug. 18 /- After a lengthy review, The SCOOTER Store, the country's leading provider of power mobility products and services, has selected an integrated Omnicom team as its new agency to help strengthen and broaden the company's brand and messaging. In addition to...
Wound Management Technologies' CellerateRX® Activated Collagenâ„¢ Debuts at the South African Diabetic Foot Working Group Congress in Cape Town
August 18, 2010 8:34 am | by Bio-Medicine.Org | CommentsFORT WORTH, Texas, Aug. 18 /- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM ) announced today that its new international distributor, Spiramed (Pty) Ltd, exhibited its advanced wound care collagen product, CellerateRX® last weekend at the DFWG (Diabetic Foot Working...
Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
August 18, 2010 8:34 am | by Bio-Medicine.Org | CommentsSAN DIEGO, Aug. 18 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, today announced that it has entered into an agreement with GVK Biosciences (GVK BIO) to expand the opportunity for...
Biogen to pay up to $345M for ALS treatment
August 18, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | CommentsBiogen Idec Inc. has entered into a licensing agreement with Pittsburgh, Pa.-based Knopp Neurosciences Inc. in which Biogen will pay up to $265 million to gain exclusive rights to develop and commercialize Knopp's treatment of amyotrophic lateral sclerosis (ALS).
Life sciences firms explore ways to help developing nations
August 18, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | CommentsIs it possible to solve a developing-world pandemic or other similar disease that afflicts the poor and still get rich? One might have to choose between one or the other, say experts, but there may be some options.
TOPEX Sells Skin Cancer Business Operations to SENSUS Healthcare
August 18, 2010 8:33 am | by Bio-Medicine.Org | CommentsDANBURY, Conn., Aug. 18 /- TOPEX, Inc. announces the sale of its skin cancer business operations to SENSUS Healthcare, LLC for its low energy SRT 100 superficial radiotherapy treatment system. Since TOPEX received FDA approval during 2007, many systems have been operating worldwide at...
Martek to Announce Third Quarter 2010 Results
August 18, 2010 8:33 am | by Bio-Medicine.Org | CommentsCOLUMBIA, Md., Aug. 18 /- Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its third quarter of fiscal 2010 on Wednesday, September 1, 2010, at approximately 4:00 p.m. Eastern Time (ET). At 4:45 p.m. ET Martek will conduct a...
CardioGenics Featured on Canada's Business News Network
August 18, 2010 8:33 am | by Bio-Medicine.Org | CommentsMISSISSAUGA, Ontario, Aug. 18 /- Dr. Yahia Gawad, CEO of CardioGenics Inc. (OTC Bulletin Board: CGNH ), developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, took part in an interview on...
AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality
August 18, 2010 8:32 am | by Bio-Medicine.Org | CommentsNORTH WALES, Pa., Aug. 18 /- AirPal ®, a leading innovator and supplier of lateral air transfer and positioning technology, has announced the expansion of its line of air-activated transfer pads to incorporate multi-purpose patient positioning functionality. "This announcement marks...
Nominations Open for 2011 Pezcoller Foundation-AACR International Award for Cancer Research
August 18, 2010 8:32 am | by AACR | CommentsPHILADELPHIA - The American Association for Cancer Research is currently accepting nominations for the prestigious Pezcoller Foundation-AACR International Award for Cancer Research.
Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in...
August 18, 2010 4:36 am | by Bio-Medicine.Org | CommentsFREMONT, Calif., Aug. 18 /- Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor...
Cardiac Dimensions® Announces Presentation of 12-Month Follow-up Data of TITAN™ Trial at European Society of Cardiology Meeting
August 18, 2010 4:36 am | by Bio-Medicine.Org | CommentsKIRKLAND, Wash., Aug. 18 /- Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN™ trial of the...
Research could change course of treatment for cancer that spreads to bones
August 18, 2010 4:35 am | by EurekAlert | Comments(Southern Methodist University) New research holds promise for people whose cancer has spread to their bones. A common treatment for such patients is radiosurgery ? even though little is known about its impact on bone strength, says Edmond Richer at Southern Methodist University, Dallas....
Out-of-the-ordinary life science ideas offer potential business success
August 17, 2010 10:32 pm | by Mass High Tech: The Journal of New England Technology | CommentsTurning a “cool idea†into the “next big thing†takes perserverence, an unwavering commitment to a vision, and usually, in the life sciences, a boatload of cash. Local entrepreneurs say the challenge lies in convincing funders (or customers) of the value proposition of the product.
